Cátedra de Inmunología, IDEHU (UBA-CONICET), Facultad de Farmacia y Bioquímica Junín 956, 1113, Buenos Aires, Argentina, Instituto de Microbiología y Parasitología Médica, IMPaM (UBA-CONICET), Facultad de Medicina, Paraguay 215, 1121 Buenos Aires, Argentina.
Evid Based Complement Alternat Med. 2013;2013:627898. doi: 10.1155/2013/627898. Epub 2013 Jun 6.
In order to find novel plant-derived biologically active compounds against Trypanosoma cruzi, we isolated, from the organic extract of Smallanthus sonchifolius, the sesquiterpene lactones enhydrin (1), uvedalin (2), and polymatin B (3) by bioassay-guided fractionation technique. These compounds showed a significant trypanocidal activity against the epimastigote forms of the parasite with IC50 values of 0.84 μ M (1), 1.09 μ M (2), and 4.90 μ M (3). After a 24 h treatment with 10 μ g/mL of enhydrin or uvedalin, parasites were not able to recover their replication rate. Compounds 1 and 2 showed IC50 values of 33.4 μ M and 25.0 μ M against T. cruzi trypomastigotes, while polymatin B was not active. When the three compounds were tested against the intracellular forms of T. cruzi, they were able to inhibit the amastigote replication with IC50 of 5.17 μ M, 3.34 μ M, and 9.02 μ M for 1, 2, and 3, respectively. The cytotoxicity of the compounds was evaluated in Vero cells obtaining CC50 values of 46.5 μ M (1), 46.8 μ M (2), and 147.3 μ M (3) and the selectivity index calculated. According to these results, enhydrin and uvedalin might have potentials as agents against Chagas disease and could serve as lead molecules to develop new drugs.
为了寻找新型植物源抗恰加斯病生物活性化合物,我们采用生物活性导向分离技术,从小叶泽兰的有机提取物中分离得到倍半萜内酯化合物 enhydrin(1)、uvedalin(2)和 polymatin B(3)。这些化合物对寄生虫的epimastigote 形式具有显著的杀锥虫活性,IC50 值分别为 0.84 μM(1)、1.09 μM(2)和 4.90 μM(3)。用 10 μM 的 enhydrin 或 uvedalin 处理 24 小时后,寄生虫无法恢复其复制率。化合物 1 和 2 对 T. cruzi trypomastigotes 的 IC50 值分别为 33.4 μM 和 25.0 μM,而 polymatin B 没有活性。当这三种化合物用于检测 T. cruzi 的细胞内形式时,它们能够以 5.17 μM、3.34 μM 和 9.02 μM 的 IC50 抑制阿米巴样繁殖,分别用于 1、2 和 3。在 Vero 细胞中评估了化合物的细胞毒性,得到 CC50 值分别为 46.5 μM(1)、46.8 μM(2)和 147.3 μM(3),并计算了选择性指数。根据这些结果,enhydrin 和 uvedalin 可能具有作为抗恰加斯病药物的潜力,并可作为开发新药物的先导分子。